The “In Vivo Toxicology Market by Product (Animal Models, Reagents & Kits), Test Type (Chronic, Sub-acute), Toxicity Endpoints (Systemic, Immunotoxicity), Testing Facility (Outsourced, In-house), End User (Academic & Research Institute, CROs) – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period.
Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing demand for personalized medicine.
By Product, the consumables segment accounted for the largest share of the in vivo toxicology market.
The in vivo toxicology market is categorized into instruments and consumables. The consumables segment is further categorized into animal models and reagents & kits. Animal models is sub-segmented into mice, rat and other animals. The consumables segment accounted for the largest share of the in vivo toxicology market in 2019. The widespread use of reagents & kits in research activities, increase in funds for research projects, and their extensive application in the in vivo toxicology studies are fueling the growth of this segment.
By toxicity endpoint, the immunotoxicity segment accounted for the largest share of the in vivo toxicology market.
The global in vivo toxicology market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental & reproductive toxicity (DART), and other toxicity endpoints (includes organ toxicity, endocrine disruptor toxicity, juvenile toxicity, phototoxicity, ocular toxicity, and skin irritation). In 2019, the immunotoxicity segment accounted for the largest share of the global in vivo toxicology market, followed by the systemic toxicity segment. The rising demand for the development of biologics and biosimilars is driving the growth of the immunotoxicity segment
By test type, chronic test type segment accounted for the largest share of the in vivo toxicology market
The global in vivo toxicology market is segmented into acute, sub-acute, sub-chronic, and chronic test type. The chronic test type segment is expected to dominate the market during the forecast period. In 2019, the chronic test type segment held the largest share of the market, followed by sub-chronic test type. Increasing research on drugs used for longer-duration therapy such as anti-cancer, anti-convulsive, anti-arthritis, and anti-hypertensives drives the growth of the chronic test type market.
By End user, Academic and Research Institutes accounted for the largest share of the in vivo toxicology market
The global in vivo toxicology market has been broadly segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users (cosmetic companies and food laboratories). The academic and research institutes segment accounted for the largest share of the in vivo toxicology market in 2019. The increasing number of research activities in the field of in vivo toxicology and funding to the academic and research institutes to conduct in vivo toxicology research are the factors responsible for the largest share of the segment
- Increasing Pharmaceutical R&D Activities
- Innovations in Animal Models
- Exclusive In Vivo Toxicology Tests
- Increasing Demand for Personalized Medicine
- Alternatives to Animal Testing
- Rising Demand for Humanized Animal Models
- Regulations and Laws for the Ethical Use of Animals in Research
- Agilent Technologies
- Bio-Rad Laboratories
- Bruker Corporation
- Charles River Laboratories
- Crown Bioscience
- Cyagen Biosciences
- Danaher Corporation
- Data Sciences International
- GE Healthcare
- Gvk Bio
- Harbour Biomed
- Ingenious Targeting Laboratory
- Janvier Labs
- Merck Kgaa
- Other Players
- Ozgene Pty Ltd.
- Shimadzu Corporation
- Taconic Biosciences
- The Jackson Laboratory
- Thermo Fisher Scientific
- Transcure Bioservices
- Waters Corporation
For more information about this report visit https://www.researchandmarkets.com/r/jrjqoj
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900